285 related articles for article (PubMed ID: 23506218)
1. Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.
Malmberg M; Ngasala B; Ferreira PE; Larsson E; Jovel I; Hjalmarsson A; Petzold M; Premji Z; Gil JP; Björkman A; Mårtensson A
Malar J; 2013 Mar; 12():103. PubMed ID: 23506218
[TBL] [Abstract][Full Text] [Related]
2. Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.
Kavishe RA; Paulo P; Kaaya RD; Kalinga A; van Zwetselaar M; Chilongola J; Roper C; Alifrangis M
Malar J; 2014 Jul; 13():264. PubMed ID: 25007802
[TBL] [Abstract][Full Text] [Related]
3. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
[TBL] [Abstract][Full Text] [Related]
4. Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya.
Achieng AO; Muiruri P; Ingasia LA; Opot BH; Juma DW; Yeda R; Ngalah BS; Ogutu BR; Andagalu B; Akala HM; Kamau E
Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):92-9. PubMed ID: 26236581
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.
Venkatesan M; Gadalla NB; Stepniewska K; Dahal P; Nsanzabana C; Moriera C; Price RN; Mårtensson A; Rosenthal PJ; Dorsey G; Sutherland CJ; Guérin P; Davis TME; Ménard D; Adam I; Ademowo G; Arze C; Baliraine FN; Berens-Riha N; Björkman A; Borrmann S; Checchi F; Desai M; Dhorda M; Djimdé AA; El-Sayed BB; Eshetu T; Eyase F; Falade C; Faucher JF; Fröberg G; Grivoyannis A; Hamour S; Houzé S; Johnson J; Kamugisha E; Kariuki S; Kiechel JR; Kironde F; Kofoed PE; LeBras J; Malmberg M; Mwai L; Ngasala B; Nosten F; Nsobya SL; Nzila A; Oguike M; Otienoburu SD; Ogutu B; Ouédraogo JB; Piola P; Rombo L; Schramm B; Somé AF; Thwing J; Ursing J; Wong RPM; Zeynudin A; Zongo I; Plowe CV; Sibley CH; Asaq Molecular Marker Study Group
Am J Trop Med Hyg; 2014 Oct; 91(4):833-843. PubMed ID: 25048375
[TBL] [Abstract][Full Text] [Related]
6. In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa.
Sisowath C; Petersen I; Veiga MI; Mårtensson A; Premji Z; Björkman A; Fidock DA; Gil JP
J Infect Dis; 2009 Mar; 199(5):750-7. PubMed ID: 19210165
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisinin-based combination therapy.
Lobo E; de Sousa B; Rosa S; Figueiredo P; Lobo L; Pateira S; Fernandes N; Nogueira F
Malar J; 2014 Aug; 13():300. PubMed ID: 25098280
[TBL] [Abstract][Full Text] [Related]
8. Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021.
Bakari C; Mandara CI; Madebe RA; Seth MD; Ngasala B; Kamugisha E; Ahmed M; Francis F; Bushukatale S; Chiduo M; Makene T; Kabanywanyi AM; Mahende MK; Kavishe RA; Muro F; Mkude S; Mandike R; Molteni F; Chacky F; Bishanga DR; Njau RJA; Warsame M; Kabula B; Nyinondi SS; Lucchi NW; Talundzic E; Venkatesan M; Moriarty LF; Serbantez N; Kitojo C; Reaves EJ; Halsey ES; Mohamed A; Udhayakumar V; Ishengoma DS
Malar J; 2024 Mar; 23(1):71. PubMed ID: 38461239
[TBL] [Abstract][Full Text] [Related]
9. Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.
Duah NO; Matrevi SA; de Souza DK; Binnah DD; Tamakloe MM; Opoku VS; Onwona CO; Narh CA; Quashie NB; Abuaku B; Duplessis C; Kronmann KC; Koram KA
Malar J; 2013 Oct; 12():377. PubMed ID: 24172030
[TBL] [Abstract][Full Text] [Related]
10. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania.
Ishengoma DS; Mandara CI; Francis F; Talundzic E; Lucchi NW; Ngasala B; Kabanywanyi AM; Mahende MK; Kamugisha E; Kavishe RA; Muro F; Mohamed A; Mandike R; Mkude S; Chacky F; Paxton L; Greer G; Kitojo CA; Njau R; Martin T; Venkatesan M; Warsame M; Halsey ES; Udhayakumar V
Malar J; 2019 Mar; 18(1):88. PubMed ID: 30898164
[TBL] [Abstract][Full Text] [Related]
12. Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.
Baraka V; Mavoko HM; Nabasumba C; Francis F; Lutumba P; Alifrangis M; Van Geertruyden JP
PLoS One; 2018; 13(2):e0191922. PubMed ID: 29390014
[TBL] [Abstract][Full Text] [Related]
13. Surveillance of genetic markers associated with Plasmodium falciparum resistance to artemisinin-based combination therapy in Pakistan, 2018-2019.
Khan AQ; Pernaute-Lau L; Khattak AA; Luijcx S; Aydin-Schmidt B; Hussain M; Khan TA; Mufti FU; Morris U
Malar J; 2020 Jun; 19(1):206. PubMed ID: 32513171
[TBL] [Abstract][Full Text] [Related]
14. Clinical isolates of uncomplicated falciparum malaria from high and low malaria transmission areas show distinct pfcrt and pfmdr1 polymorphisms in western Ethiopia.
Tadele G; Jawara A; Oboh M; Oriero E; Dugassa S; Amambua-Ngwa A; Golassa L
Malar J; 2023 Jun; 22(1):171. PubMed ID: 37270589
[TBL] [Abstract][Full Text] [Related]
15. Selection of
Maiga H; Grivoyannis A; Sagara I; Traore K; Traore OB; Tolo Y; Traore A; Bamadio A; Traore ZI; Sanogo K; Doumbo OK; Plowe CV; Djimde AA
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205228
[TBL] [Abstract][Full Text] [Related]
16. Reduced ex vivo susceptibility of Plasmodium falciparum after oral artemether-lumefantrine treatment in Mali.
Dama S; Niangaly H; Ouattara A; Sagara I; Sissoko S; Traore OB; Bamadio A; Dara N; Djimde M; Alhousseini ML; Goita S; Maiga H; Dara A; Doumbo OK; Djimde AA
Malar J; 2017 Feb; 16(1):59. PubMed ID: 28148267
[TBL] [Abstract][Full Text] [Related]
17. Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.
Somé AF; Séré YY; Dokomajilar C; Zongo I; Rouamba N; Greenhouse B; Ouédraogo JB; Rosenthal PJ
Antimicrob Agents Chemother; 2010 May; 54(5):1949-54. PubMed ID: 20231394
[TBL] [Abstract][Full Text] [Related]
18. Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.
Mwaiswelo R; Ngasala B; Jovel I; Aydin-Schmidt B; Gosling R; Premji Z; Mmbando B; Björkman A; Mårtensson A
Malar J; 2016 Aug; 15(1):435. PubMed ID: 27565897
[TBL] [Abstract][Full Text] [Related]
19. Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration.
Srimuang K; Miotto O; Lim P; Fairhurst RM; Kwiatkowski DP; Woodrow CJ; Imwong M;
Malar J; 2016 Nov; 15(1):541. PubMed ID: 27825353
[TBL] [Abstract][Full Text] [Related]
20. Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal.
Mbaye A; Dieye B; Ndiaye YD; Bei AK; Muna A; Deme AB; Yade MS; Diongue K; Gaye A; Ndiaye IM; Ndiaye T; Sy M; Diallo MA; Badiane AS; Ndiaye M; Seck MC; Sy N; Koita O; Krogstad DJ; Nwakanma D; Ndiaye D
Malar J; 2016 Aug; 15(1):433. PubMed ID: 27562216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
